#4-44E. Rewiring the Brain: Unraveling the Pathophysiology of Fatigue in Rheumatic Diseases (Rheumatology, 2019)

Do you have patients who continue to suffer from debilitating fatigue even after achieving clinical remission for their inflammatory rheumatic diseases? This episode delves into a comprehensive review investigating how the activated immune system hijacks the brain's neurochemistry. The authors explain that chronic inflammation alters the balance of neurotransmitters, significantly decreasing monoaminergic activity and increasing glutamatergic neurotransmission, which ultimately drives motivational, physical, and cognitive fatigue. The most critical clinical insight is that chronic inflammation can induce central nervous system sensitization, perpetuating this severe fatigue independently of joint pain. However, when critically appraising this paper, clinicians must consider the inherent difficulty in fully isolating the direct effects of inflammation from other significant confounding factors, such as sleep disturbances, decreased mobility, and concomitant depression. Understanding these complex pathophysiological pathways is highly relevant for physicians, as it clearly explains why conventional anti-inflammatory treatments often fail to resolve residual fatigue. This essential knowledge empowers clinicians to improve patient education, manage expectations, and adopt more holistic, multidisciplinary care strategies in daily practice.

Citation: Korte SM, Straub RH. Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms. Rheumatology. 2019. DOI: 10.1093/rheumatology/kez413

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.